Skip to content

The efficacy and safety of bright light therapy combined with escitalopram oxalate in the treatment of sleep disorders associated with post-stroke depression

Light Therapy for PSD

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029450
Enrollment
Unknown
Registered
2020-02-02
Start date
2020-02-05
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke depression

Interventions

monotherapy group:escitalopram oxalat, 10 mg,qm
combination therapy group:escitalopram oxalat, 10 mg,qm and BLT 30min qd

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 18-80 years old; (2) The diagnosis conforms to the diagnostic criteria in the Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2014; (3) At the first month of onset, the hamd-17 score was >= 8 points and the PSQI score was greater than 7 points, indicating the existence of sleep disorders. (4) The patient and his family members voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Lacunar cerebral infarction without neurological defect; (2) The combination of serious aphasia can not cooperate; (3) Patients with severe cognitive dysfunction, visual and auditory impairment, etc. who cannot complete the evaluation; (4) With a history of central nervous system diseases, such as Parkinson's disease, senile dementia, brain trauma, etc.; (5) Have depression or are taking antidepressants; (6) Previous history of stroke and left no nerve functional defect; (7) Before the onset of insomnia; (8) Today with serious internal diseases, such as liver and kidney failure, heart failure and tumor; (9) The information is incomplete and we cannot insist on following visitors.

Design outcomes

Primary

MeasureTime frame
hamd-17 score, PSQI score and Epworth score, PSG test and ADL score;

Countries

China

Contacts

Public ContactMeijuan Xiao

The First Affiliated Hospital of Wenzhou Medical University

xiaomeijuan0503@126.com+86 15868724636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026